Weaver Consulting Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Weaver Consulting Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17	Closed	-$1K	–	695
2020 Q3	$1K	Hold	17	–	–	﹤0.01%	916
2020 Q2	$1K	Hold	17	–	–	﹤0.01%	892
2020 Q1	$1K	Hold	17	–	–	﹤0.01%	801
2019 Q4	$1K	Hold	17	–	–	﹤0.01%	814
2019 Q3	$1K	Hold	17	–	–	﹤0.01%	795
2019 Q2	$1K	Hold	17	–	–	﹤0.01%	783
2019 Q1	$1K	Buy	+17	New	+$1K	﹤0.01%	1439

Other funds holding PPH

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

22CM

20/20 Capital Management Costa Mesa, California $386M AUM 30.28% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Weaver Consulting Group's PPH Position: Q4 2020 in Review

Weaver Consulting Group sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2020, closing a stake of 17 shares — an estimated $1K sold.

Weaver Consulting Group first reported a position in PPH in Q1 2019 and held it in 7 quarters. The position peaked at $1K in Q3 2020. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2020.

Weaver Consulting Group reported no remaining VanEck Pharmaceutical ETF position as of Q4 2020 after selling out during the quarter.
Weaver Consulting Group sold 17 VanEck Pharmaceutical ETF shares in Q4 2020, an estimated $1K.
Weaver Consulting Group first reported a position in VanEck Pharmaceutical ETF in Q1 2019 and held it in 7 quarters.
Weaver Consulting Group's VanEck Pharmaceutical ETF position peaked at $1K in Q3 2020.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.